| Tag | Content |
|---|
EnhancerAtlas ID | HS177-14522 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr22:32072400-32073250 |
Target genes | | Number: 11 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF5 | MA0599.1 | chr22:32072862-32072872 | GCCCCGCCCC | + | 6.02 | | NFYA | MA0060.3 | chr22:32072885-32072896 | AGCCAATCAGA | + | 6.32 | | USF1 | MA0093.2 | chr22:32072777-32072788 | ACCACGTGACC | + | 6.32 | | USF2 | MA0526.2 | chr22:32072775-32072791 | TAACCACGTGACCCTC | - | 6.33 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_10007 | chr22:32072142-32073464 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I031676 | chr22 | 32072188 | 32073393 |
|
Enhancer Sequence | TACTTTGGGA TCTGTCCCCC ATCCCTGTGT TTGCAGTGTT TCAGCGACCA TTTCAACATC 60
TCCAAAAGTC TAAGATTAAA AATGCAAAAG AAAAGAGAGA AACTGCTTAG GCGAGTCTTT 120
CTCCCAGGCT GGAGTGCAGT GGCGCGACCT CGGCTCACGG CACCTACAGT CTCCCGAGTT 180
CAAGCGATTC TTCTGCCTCA GCTTCCCGAG TAGCTGGGAT TACAGGCGCG CGCCACCACT 240
CCCGGCTAAT TTTTTGTATT TTTAGTAGAG TCACCAGGTT GGCCAGGCCT GTCTCAAGTG 300
ATCCGCCCGC CTCTGCCTCC CAAAGTGCTG GGATTACAGG CTTGAGTCAC CGCGCCCGGC 360
CCACGTGGCG AGTCTTAACC ACGTGACCCT CCCCGCTCTC CAGCCCGGCA GGTACCAGCA 420
AAGGACTAGC AGCCTCCTCC AATATGGATA GCTTCTCGGA TGGCCCCGCC CCTCCGGAGA 480
GCTGCAGCCA ATCAGACGGC GTGAGGCCAG CAGTGGGTGC GGCTGCGCTT GGCGCTGCGC 540
ATATCCGAAT ACCAGGAAGT GCCCGGTTTC GCTGTCAGTG CTCGGGCAGC TAGAATCCAG 600
GTCCCTTGAG GAATAATTTA AGAAGGGGTG GAGAAAAATT AGGGGGCGTC TTCAAATATT 660
CAGAGAGTCA GCGAGGTAAA GAGGACTTGG GCAGGTCTGT GTAGCAACGG GGGCGGGAAT 720
CATTCATTGA CGCATGAAGT ATTTCCTGAG CTCCCACCAC GTAAGACCAA GTTTTGTTCT 780
AGATGTCCGA GGGGCCAGAG TGAATATAGC AAAGTCTTTG ACCTCAAGGA GCTTAACGTG 840
AATAATATGG 850
|
